OTC Medicines

Select an Issue

Browse OTC Medicines Content

three edison lightbulbs on a dark blue background

Research Reports

Insights with Impact: Medicare Advantage Plans Expand Supplemental Benefits to Address Whole-Person Health

Trends in newly expanded supplemental benefits show enrollment growth in plans that offer an over-the-counter (OTC) benefit.

Aug 1, 2020

OTC spray in a shopping cart

Infographic

HSA/FSA Campaign: Allergy Relief & Wallet Relief

Jul 31, 2020

Pills and medicine bottles on teal and light blue backgrounds

Infographic

HSA/FSA Campaign: Pain Relief & Wallet Relief

Jul 31, 2020

Liquid medicine in a cap with bottle in background

Infographic

HSA/FSA Campaign: Soothe Aches & Payments

Jul 31, 2020

Blue and orange infographic showing the $146 billion value OTC medicines provide annually

Infographic

OTC Medicines Provide $146 Billion in Value to the U.S. Healthcare System Annually

OTC medicines are accessible, affordable, and trusted solutions that provide $146 billion in value to the U.S. healthcare system annually.

Jul 31, 2020

OTC medicine bottles on dark and light blue background

Infographic

HSA/FSA Campaign: Reduce Fevers & Expenses

Jul 31, 2020

parents with sick children

Press Releases and Statements

CHPA Statement: CDC’s JAMA Article on Decrease in Pediatric Medication Overdoses

CHPA released the following statement in response to the CDC Viewpoints article titled, “Prevention of Unintentional Medication Overdose Among Children,” published in the Journal of the American Medical Association.

Jul 28, 2020

Seniors reading medicine bottle labels in pharmacy

Articles

Timeline for Implementation of OTC Monograph Reform Fees Under Provisions in H.R. 748 (the CARES Act)

What follows is a timeline for implementation of OTC monograph reform under HR 748, also known as the CARES Act.

Jun 23, 2020

blue coronavirus particles on dark background

Press Releases and Statements

CHPA Statement Regarding Recent Observational Studies of NSAIDs and COVID-19

The results of nearly all recent observational studies of patients from around the world diagnosed with COVID-19 show no association between exposure to NSAIDs (including ibuprofen) and worsening clinical outcomes.

Jun 23, 2020

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Launches Rebranding Effort as Consumer Health Becomes More Vital to Public Health

CHPA is rebranding its identity for the first time in 20 years. The rebranding effort has resulted in a new logo, tagline, and brand narrative following the addition of consumer medical devices to its scope of representation.

Jun 1, 2020

Filter Results